Phase IV drug trial refers to

• A. Post-market surveillance
• B. Early stage nonclinical studies
• C. Preclinical safety testing
• D. Manufacturing validation

Answer: (A)

Phase IV is post-marketing surveillance conducted after approval to monitor a drug's safety in real-world use. Once a medication is on the market, Phase IV studies collect long-term safety data, detect rare or delayed adverse events, assess effectiveness across broader and more diverse patient populations, and evaluate drug interactions or risks in specific subgroups. This stage helps refine the safety profile and labeling based on actual use outside controlled trial settings. Early-stage nonclinical studies and preclinical safety testing occur before humans and are not clinical trial phases, while manufacturing validation ensures production quality rather than evaluating patient safety after approval.